Does VEDOLIZUMAB Cause Therapy responder? 6 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 6 reports of Therapy responder have been filed in association with VEDOLIZUMAB (ENTYVIO). This represents 0.0% of all adverse event reports for VEDOLIZUMAB.
6
Reports of Therapy responder with VEDOLIZUMAB
0.0%
of all VEDOLIZUMAB reports
0
Deaths
1
Hospitalizations
How Dangerous Is Therapy responder From VEDOLIZUMAB?
Of the 6 reports, 1 (16.7%) required hospitalization.
Is Therapy responder Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for VEDOLIZUMAB. However, 6 reports have been filed with the FAERS database.
What Other Side Effects Does VEDOLIZUMAB Cause?
Off label use (21,017)
Colitis ulcerative (13,455)
Crohn's disease (9,759)
Drug ineffective (8,424)
Diarrhoea (7,493)
Abdominal pain (6,401)
Fatigue (5,477)
Haematochezia (5,215)
Frequent bowel movements (4,527)
Arthralgia (4,028)
What Other Drugs Cause Therapy responder?
CYCLOPHOSPHAMIDE (157)
RITUXIMAB (78)
VINCRISTINE (61)
PREDNISONE (60)
BEVACIZUMAB (41)
EPIRUBICIN (35)
CISPLATIN (34)
ETOPOSIDE (32)
ANTI-INHIBITOR COAGULANT COMPLEX (30)
COAGULATION FACTOR VIIA RECOMBINANT HUMAN (30)
Which VEDOLIZUMAB Alternatives Have Lower Therapy responder Risk?
VEDOLIZUMAB vs VELAGLUCERASE ALFA
VEDOLIZUMAB vs VELCADE
VEDOLIZUMAB vs VELETRI
VEDOLIZUMAB vs VELIPARIB
VEDOLIZUMAB vs VEMURAFENIB